Cyanotech Corporation (CYAN)
Cyanotech Corporation Revenue Growth: 71.12%
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
CYAN Revenue Growth Rankings
| Overall | 94th percentile | 219 of 4358 |
| Sector | 88th percentile | 54 of 456 in Healthcare |
| Industry | 90th percentile | 1 of 10 in Drug Related Products |
CYAN Revenue Growth Range, Past 5 Years
| Minimum | -4.10% | Jun 2010 |
| Maximum | 71.12% | Dec 2011 |
| Average | 22.70% |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
You may also be interested in these CYAN related companies
CYAN News
$CYAN CNBC was showing $CYAN down 18% on 95000 shares vol now down 1.3% on 34k ???
about 10 days ago by theQu4nt
about 10 days ago by theQu4nt
$CYAN Nasdaq stocks posting largest percentage decreases http://stks.co/3sq8 $$
about 11 days ago by theQu4nt
about 11 days ago by theQu4nt
$CYAN Nutrex Hawaii Announces Scientific Advisory Board http://stks.co/3rt6 $$
about 11 days ago by theQu4nt
about 11 days ago by theQu4nt
$CYAN has still not reported FY 2012 numbers ending March 31 and no news since 2/9 http://stks.co/3rc2 #EpicFail #NoCorporateGovernance $$
about 12 days ago by theQu4nt
about 12 days ago by theQu4nt
$CYAN has still nor reported FY 2012 numbers ending March 31 and no news since 2/9 http://stks.co/3rbs #EpicFail #NoCorporateGovernance $$
about 12 days ago by theQu4nt
about 12 days ago by theQu4nt
$CYAN forms bullish "Triple Bottom" chart pattern. http://stks.co/3aqV
about 28 days ago by RecogniaEvents
about 28 days ago by RecogniaEvents
$CYAN forms bullish "Symmetrical Continuation Triangle" chart pattern. http://stks.co/3Yve
about 31 days ago by RecogniaEvents
about 31 days ago by RecogniaEvents
$PVSW $GKNT $CYAN Analysts Ratings via TDAmeritrade as of April 15 http://stks.co/3LpI (comment #8) $$
about 43 days ago by theQu4nt
about 43 days ago by theQu4nt
$CYAN forms bullish "Continuation Wedge" chart pattern. http://stks.co/3JQ6
about 47 days ago by RecogniaEvents
about 47 days ago by RecogniaEvents
$CYAN Q4 FY 2012 $PVSW Q3 FY 2012 $GKNT Q1 FY 2012 Ending March 31 Numbers Pending http://stks.co/3A6q #study $$
about 59 days ago by theQu4nt
about 59 days ago by theQu4nt
$CYAN Congratulations http://stks.co/2ltr (comment3) for xing into double-digits and closing at a new ten-year high http://stks.co/2lts $$
about 79 days ago by theQu4nt
about 79 days ago by theQu4nt
$CYAN crosses into double-digits hitting another 52-week and closing at a ten-year high http://stks.co/2lnE #astaxanthin #spirulina $$
about 80 days ago by theQu4nt
about 80 days ago by theQu4nt
$CYAN Up 10.1% on 2.7X ADV (3 mo) Closes at $9.85 Making New 52-week High at $10.10 http://stks.co/2kMa #Astaxanthin #Spirulina $$
about 81 days ago by theQu4nt
about 81 days ago by theQu4nt
Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2012
Feb 09, 6:00AM Business Wire
Feb 09, 6:00AM Business Wire
Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2012
Nov 14, 8:00AM Business Wire
Nov 14, 8:00AM Business Wire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CYAN | 7.60 | -0.15 | -1.94% | 41.12M |
| CY | 13.25 | +0.11 | +0.84% | 2.052B |
| CSGS | 16.38 | +0.09 | +0.55% | 565.27M |
| CSGP | 72.67 | -0.29 | -0.40% | 1.849B |
| CSFS | 5.50 | +0.00 | +0.00% | 95.86M |
| CSFL | 7.31 | -0.21 | -2.79% | 219.81M |
| CSE | 6.41 | -0.03 | -0.47% | 1.553B |
| CRVL | 43.69 | +0.82 | +1.91% | 499.38M |
| CRV | 2.293 | +0.00 | +0.00% | 10.96M |
| CRUS | 27.45 | +0.29 | +1.07% | 1.760B |
